| scholarly article | Q13442814 |
| P356 | DOI | 10.1139/O86-026 |
| P698 | PubMed publication ID | 3521675 |
| P2093 | author name string | Schachter H | |
| P433 | issue | 3 | |
| P921 | main subject | oligosaccharide | Q320607 |
| P304 | page(s) | 163-181 | |
| P577 | publication date | 1986-03-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Biochemistry and Cell Biology | Q4914719 |
| P1476 | title | Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. | |
| P478 | volume | 64 |
| Q92636361 | 3D Structure and Function of Glycosyltransferases Involved in N-glycan Maturation |
| Q38322963 | 5-Propyl-2-deoxyuridine induced interference with glycosylation in herpes simplex virus infected cells. Nature of PdU-induced modifications of N-linked glycans. |
| Q43849868 | A catalytically inactive β1,4‐N‐acetylglucosaminyltransferase III (GnT‐III) behaves as a dominant negative GnT‐III inhibitor |
| Q33251607 | A deletion in the golgi alpha-mannosidase II gene of Caenorhabditis elegans results in unexpected non-wild-type N-glycan structures |
| Q67908028 | A simple synthesis of octyl 3,6-di-O-(?-d-mannopyranosyl)-?-d-mannopyranoside and its use as an acceptor for the assay ofN-acetylglucosaminyltransferase-I activity |
| Q31806373 | A solid-phase glycosyltransferase assay for high-throughput screening in drug discovery research |
| Q80352658 | A sugar-coated switch for cellular growth and arrest |
| Q73248518 | A two-site lectinoenzymatic assay for determination of tumour marker glycoproteins in rectal secretions |
| Q58867625 | A unique, terminally glucosylated oligosaccharide is a common feature on Leishmania cell surfaces |
| Q35883056 | Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia |
| Q40524463 | Abnormal biantennary sugar chains are expressed in human chorionic gonadotropin produced in the choriocarcinoma cell line, JEG-3. |
| Q36872019 | Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. |
| Q34032244 | Antithrombin Murcia (K241E) causing antithrombin deficiency: a possible role for altered glycosylation |
| Q68465998 | Assembly of asparagine-linked oligosaccharides in baby hamster kidney cells treated with castanospermine, an inhibitor of processing glucosidases |
| Q47683221 | Bactericidal Activity and Poly-l-proline II Conformation of the Tandem Repeat Sequence of Human Salivary Mucin Glycoprotein (MG2) |
| Q38544783 | Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer |
| Q30493173 | Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility |
| Q38348733 | Carbohydrate Binding Activity of Annexin V toward a Bisecting N-Acetylglucosamine |
| Q33624870 | Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. |
| Q42862337 | Carbohydrate structure of human pancreatic elastase 1. |
| Q33778404 | Carbohydrate-deficient glycoprotein syndrome type II. |
| Q52996952 | Cell Surface Glycoproteins Undergo Postbiosynthetic Modification of Their N-Glycans by Stepwise Demannosylation |
| Q33880892 | Characterization of a core alpha1-->3-fucosyltransferase from the snail Lymnaea stagnalis that is involved in the synthesis of complex-type N-glycans |
| Q71783177 | Characterization of changes in the glycosylation pattern of recombinant proteins from BHK-21 cells due to different culture conditions |
| Q78167679 | Characterization of human vascular endothelial cadherin glycans |
| Q42853848 | Characterization of recombinant lysyl oxidase propeptide |
| Q28546845 | Chemical Characterization of N-Linked Oligosaccharide As the Antigen Epitope Recognized by an Anti-Sperm Auto-Monoclonal Antibody, Ts4 |
| Q74734845 | Chemoenzymatic synthesis of a sialylated diantennary N-glycan linked to asparagine |
| Q34371750 | Chemoselective approaches to glycoprotein assembly |
| Q24292023 | Cloning and expression of a novel UDP-GlcNAc:alpha-D-mannoside beta1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:alpha-3-D-mannoside beta1,2-N-acetylglucosaminyltransferase I |
| Q56566912 | Cloning and expression of a novel UDP-GlcNAc:α-d-mannoside β1,2-N-acetylglucosaminyltransferase homologous to UDP-GlcNAc:α-3-d-mannoside β1,2-N-acetylglucosaminyltransferase I |
| Q35932897 | Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines |
| Q40372604 | Comparison of RP-HPLC modes to analyse the N-glycome of the free-living nematode Pristionchus pacificus. |
| Q35832941 | Comparisons of Caenorhabditis Fucosyltransferase Mutants Reveal a Multiplicity of Isomeric N-Glycan Structures |
| Q91699744 | Comparisons of N-glycans across invertebrate phyla |
| Q38328115 | Complementarity between sperm surface beta-1,4-galactosyltransferase and egg-coat ZP3 mediates sperm-egg binding |
| Q38040261 | Complicated N-linked glycans in simple organisms |
| Q38350305 | Current ideas on the significance of protein glycosylation |
| Q41719311 | Defective Glycosyltransferases are Not Good for Your Health |
| Q50200755 | Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function. |
| Q52186694 | Developmental Changes in the Glycosylation of Glycoprotein Hormone Free α Subunit during Pregnancy |
| Q34580383 | Direct determination of multiple ligand interactions with the extracellular domain of the calcium-sensing receptor |
| Q35925263 | Ectopic expression of N -acetylglucosaminyltransferase III in transgenic hepatocytes disrupts apolipoprotein B secretion and induces aberrant cellular morphology with lipid storage |
| Q83311631 | Effects of Single Genetic Damage in Carbohydrate‐Recognizing Proteins in Mouse Serum N‐Glycan Profile Revealed by Simple Glycotyping Analysis |
| Q41661881 | Effects of brefeldin A on oligosaccharide processing. Evidence for decreased branching of complex-type glycans and increased formation of hybrid-type glycans |
| Q41262405 | Effects of dibutyryl cAMP and bromodeoxyuridine on expression of N-acetylglucosaminyltransferases III and V in GOTO neuroblastoma cells |
| Q33995031 | Emerging themes in medicinal glycoscience |
| Q31214737 | Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity |
| Q35285380 | Environmental effects on protein glycosylation |
| Q26748089 | Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer |
| Q83112607 | Epigenetic modulation of the HeLa cell membrane N-glycome |
| Q36674650 | Expression of N-Acetylglucosaminyltransferase III Suppresses α2,3-Sialylation, and Its Distinctive Functions in Cell Migration Are Attributed to α2,6-Sialylation Levels |
| Q42068430 | Expression of recombinant rabbit UDP-GlcNAc: alpha 3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I catalytic domain in Sf9 insect cells |
| Q52124760 | Expression of specific glycoconjugates in both primary and secondary olfactory pathways in BALB/C mice |
| Q33783756 | Fucose in N-glycans: from plant to man. |
| Q34451930 | Function characterization of a glyco-engineered anti-EGFR monoclonal antibody cetuximab in vitro |
| Q36217186 | Galactosylated fucose epitopes in nematodes: increased expression in a Caenorhabditis mutant associated with altered lectin sensitivity and occurrence in parasitic species. |
| Q34589283 | Galactosyltransferase 4 is a major control point for glycan branching in N-linked glycosylation |
| Q77376179 | Gene expression and regulation of N-acetylglucosaminyltransferases III and V in cancer tissues |
| Q40990280 | Genetic defect in N-acetylglucosaminyltransferase I gene of a ricin-resistant baby hamster kidney mutant. |
| Q34489534 | Genetic defects in N-glycosylation and cellular diversity in mammals |
| Q35663970 | Genetic variants near the MGAT1 gene are associated with body weight, BMI and fatty acid metabolism among adults and children |
| Q40862070 | Glycans of higher plant peroxidases: recent observations and future speculations |
| Q43960333 | Glycobiology in medicine |
| Q38141958 | Glycoconjugates and cell surface interactions in pre- and peri-implantation mammalian embryonic development |
| Q46714010 | Glycogen storage disease Ib: modification of alpha 1-antitrypsin glycoprotein microheterogeneity |
| Q39394553 | Glycomics for Drug Discovery: Metabolic Perturbation in Androgen‐Independent Prostate Cancer Cells Induced by Unnatural Hexosamine Mimics |
| Q44021323 | Glycoprotein glycosyltransferase activities in serum in alcohol-abusing patients and healthy controls |
| Q34074081 | Glycosylation defining cancer malignancy: new wine in an old bottle |
| Q37343144 | Glycosylation diseases: quo vadis? |
| Q34026756 | Glycosylation of mouse and human immune cells: insights emerging from N-glycomics analyses |
| Q51766703 | Glycosylation profiles of therapeutic antibody pharmaceuticals |
| Q34771274 | Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism. |
| Q33885275 | Golgi N-glycosyltransferases form both homo- and heterodimeric enzyme complexes in live cells |
| Q30379238 | Golgi self-correction generates bioequivalent glycans to preserve cellular homeostasis. |
| Q45841059 | Herpes simplex virus infection of the human sensory neuron. An electron microscopy study |
| Q38301899 | Human FSH isoforms: carbohydrate complexity as determinant of in-vitro bioactivity |
| Q24535259 | Human meprin beta: O-linked glycans in the intervening region of the type I membrane protein protect the C-terminal region from proteolytic cleavage and diminish its secretion |
| Q38013479 | IgG-Fc glycoengineering in non-mammalian expression hosts |
| Q33778442 | Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism |
| Q34421546 | Improved mass spectrometric characterization of protein glycosylation reveals unusual glycosylation of maize-derived bovine trypsin. |
| Q59132146 | Improving Immunotherapy Through Glycodesign |
| Q41699139 | Increased UDP-GlcNAc:Gal beta 1-3GaLNAc-R (GlcNAc to GaLNAc) beta-1, 6-N-acetylglucosaminyltransferase activity in metastatic murine tumor cell lines. Control of polylactosamine synthesis |
| Q38336780 | Inhibition of L- and P-selectin by a rationally synthesized novel core 2-like branched structure containing GalNAc-Lewisx and Neu5Ac 2-3Gal 1-3GalNAc sequences |
| Q55416256 | Inhibition of poly-LacNAc biosynthesis with release of CMP-Neu5Ac feedback inhibition increases the sialylation of recombinant EPO produced in CHO cells. |
| Q28361637 | Insect cells encode a class II alpha-mannosidase with unique properties |
| Q41343135 | Insertion into Aspergillus nidulans of functional UDP-GlcNAc: alpha 3-D- mannoside beta-1,2-N-acetylglucosaminyl-transferase I, the enzyme catalysing the first committed step from oligomannose to hybrid and complex N-glycans |
| Q38339188 | Interaction of egg-white glycoproteins and their oligosaccharides with the monomer and the hexamer of chicken liver lectin. A multivalent oligosaccharide-combining site exists within the carbohydrate-recognition domain |
| Q72254508 | Key involvement of all three GlcNAc hydroxyl groups in the recognition of beta-D-GlcpNAc-(1-->2)-alpha-D-Manp-(1-->6)-beta-D-Glcp-OR by N-acetylglucosaminyltransferase-V |
| Q41418904 | Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain |
| Q74476721 | MMC and LD simulations of alpha-D-Manp-(1-->2)-beta-D-Glcp-OMe: comparison to long-range heteronuclear NMR coupling constants and to the crystal structure |
| Q38613949 | Malignant cell glycoproteins and glycolipids |
| Q91742935 | Mechanistic reconstruction of glycoprotein secretion through monitoring of intracellular N-glycan processing |
| Q35955540 | Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways |
| Q37671886 | Metabolism, cell surface organization, and disease |
| Q28589941 | Mice with a homozygous deletion of the Mgat2 gene encoding UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II: a model for congenital disorder of glycosylation type IIa |
| Q36466243 | MicroRNA-424 Predicts a Role for β-1,4 Branched Glycosylation in Cell Cycle Progression. |
| Q37183398 | Molecular Characterization of Myelin Protein Zero in Xenopus laevis Peripheral Nerve: Equilibrium between Non-covalently Associated Dimer and Monomer |
| Q37479275 | Molecular basis for galactosylation of core fucose residues in invertebrates: identification of caenorhabditis elegans N-glycan core alpha1,6-fucoside beta1,4-galactosyltransferase GALT-1 as a member of a novel glycosyltransferase family |
| Q33318026 | Molecular cloning and expression of cDNA encoding the enzyme that controls conversion of high-mannose to hybrid and complex N-glycans: UDP-N-acetylglucosamine: alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I |
| Q24675799 | Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development |
| Q37142796 | N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc |
| Q64227114 | N-acetylglucosaminyltransferases and nucleotide sugar transporters form multi-enzyme-multi-transporter assemblies in golgi membranes in vivo |
| Q52674607 | N-glycans are involved in the response of Caenorhabditis elegans to bacterial pathogens |
| Q92821732 | N-glycome inheritance from cells to extracellular vesicles in B16 melanomas |
| Q42258662 | N-glycosylation engineering of plants for the biosynthesis of glycoproteins with bisected and branched complex N-glycans |
| Q41041468 | N-glycosylation of a baculovirus-expressed recombinant glycoprotein in three insect cell lines |
| Q34264310 | N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. |
| Q45805135 | Network inference from glycoproteomics data reveals new reactions in the IgG glycosylation pathway |
| Q89126887 | Neural functions of bisecting GlcNAc |
| Q52679962 | Neutral N-glycan patterns of the gastropods Limax maximus, Cepaea hortensis, Planorbarius corneus, Arianta arbustorum and Achatina fulica |
| Q73010154 | New synthetic trisaccharide inhibitors for N-acetylglucosaminyltransferase-V |
| Q38362085 | O-linked protein glycosylation structure and function |
| Q24322834 | Oligosaccharide preferences of beta1,4-galactosyltransferase-I: crystal structures of Met340His mutant of human beta1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety |
| Q24530034 | Organization of the human beta-1,2-N-acetylglucosaminyltransferase I gene (MGAT1), which controls complex and hybrid N-glycan synthesis |
| Q89885926 | Partial silencing of fucosyltransferase 8 gene expression inhibits proliferation of Ishikawa cells, a cell line of endometrial cancer |
| Q36667067 | Phenotype changes of Fut8 knockout mouse: core fucosylation is crucial for the function of growth factor receptor(s). |
| Q41907848 | Pyrimidine nucleotide metabolism in rat hepatocytes: evidence for compartmentation of nucleotide pools |
| Q84980033 | Rapid LC–MS screening for IgG Fc modifications and allelic variants in blood |
| Q41071120 | Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases |
| Q36382577 | Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. |
| Q51770096 | Regulation of Epidermal Growth Factor Receptor Through Interaction of Ganglioside GM3 with GlcNAc of N-Linked Glycan of the Receptor: Demonstration in ldlD Cells |
| Q34385160 | Role of galectins in re-epithelialization of wounds |
| Q36265843 | Should we use carbohydrate deficient transferrin as a marker for alcohol abusers? |
| Q33852271 | Silibinin inhibits ICAM-1 expression via regulation of N-linked and O-linked glycosylation in ARPE-19 cells |
| Q41037223 | Strict order of (Fuc to Asn-linked GlcNAc) fucosyltransferases forming core-difucosylated structures. |
| Q42161016 | Structural analysis of the N-glycans from human immunoglobulin A1: comparison of normal human serum immunoglobulin A1 with that isolated from patients with rheumatoid arthritis |
| Q74476723 | Studies on the conformational behaviour of GlcNAc-Man3-GlcNAc2 oligosaccharides using molecular dynamics simulations |
| Q37882021 | Subunit assembly and functional maturation of Na,K-ATPase |
| Q34407965 | Suppression of cancer progression by MGAT1 shRNA knockdown. |
| Q33924286 | Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection |
| Q73888424 | Synthesis and evaluation of eight aminodeoxy trisaccharide inhibitors for N-acetylglucosaminyltransferase-V |
| Q41035181 | Synthesis of Bisected Glycoforms of Recombinant IFN‐β by Overexpression of β‐1,4‐N‐Acetylglucosaminyltransferase III in Chinese Hamster Ovary Cells |
| Q46722058 | Synthesis of Complex Carbohydrates and Glycoconjugates: Enzyme-Based and Programmable One-Pot Strategies |
| Q44785745 | Synthesis of modified oligosaccharides of the N-glycoprotein as substrate for N-acetylglucosaminyltransferase I |
| Q67868151 | Synthesis of partial structure of complex types of N-glycoproteins |
| Q72649155 | Synthetic neoglycoconjugates in glycosyltransferase assay and purification |
| Q71368265 | Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-3R beta 1-2-N-acetylglucosaminyltransferase I. Substrate specificity and inhibitors for the enzyme |
| Q72499913 | Synthetic substrate analogues for UDP-GlcNAc: Man alpha 1-6R beta(1-2)-N-acetylglucosaminyltransferase II. Substrate specificity and inhibitors for the enzyme |
| Q34044337 | The N-glycans of Trichomonas vaginalis contain variable core and antennal modifications. |
| Q28510399 | The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function |
| Q38287488 | The action of N-acetylglucosaminyltransferase-V is prevented by the bisecting GlcNAc residue at the catalytic step |
| Q36949362 | The diversity of O-linked glycans expressed during Drosophila melanogaster development reflects stage- and tissue-specific requirements for cell signaling |
| Q38341725 | The effect of castanospermine on the synthesis of synaptic glycoproteins by rat brain slices |
| Q41784387 | The effect of increasing nucleotide-sugar concentrations on the incorporation of sugars into glycoconjugates in rat hepatocytes. |
| Q52368244 | The glycomic effect of N-acetylglucosaminyltransferase III overexpression in metastatic melanoma cells. GnT-III modifies highly branched N-glycans. |
| Q46787094 | The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer |
| Q24321959 | The human UDP-N-acetylglucosamine: alpha-6-D-mannoside-beta-1,2- N-acetylglucosaminyltransferase II gene (MGAT2). Cloning of genomic DNA, localization to chromosome 14q21, expression in insect cells and purification of the recombinant protein |
| Q34290881 | The joys of HexNAc. The synthesis and function of N- and O-glycan branches |
| Q34989555 | The role of the GlcNAc(beta)1,2Man(alpha)- moiety in mammalian development. Null mutations of the genes encoding UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-D-mannoside bet |
| Q48040862 | Time-resolved fluorescence imaging reveals differential interactions of N-glycan processing enzymes across the Golgi stack in planta |
| Q38337853 | Transcriptional regulation of the human UDP-GlcNAc:alpha-6-D-mannoside beta-1-2-N-acetylglucosaminyltransferase II gene (MGAT2) which controls complex N-glycan synthesis |
| Q73429191 | Transferrin microheterogeneity in pregnancies with preeclampsia |
| Q39760903 | Tumor cell surface carbohydrate and the metastatic phenotype |
| Q35554103 | Tumor-Associated Carbohydrate Antigens Defining Tumor Malignancy: Basis for Development of Anti-Cancer Vaccines |
| Q33187470 | Two closely related forms of UDP-GlcNAc: alpha6-D-mannoside beta1,2-N-acetylglucosaminyltransferase II occur in the clawed frog Xenopus laevis |
| Q34989546 | UDP-N-acetylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I and UDP-N-acetylglucosamine:alpha-6-D-mannoside beta-1,2-N-acetylglucosaminyltransferase II in Caenorhabditis elegans |
| Q34989618 | UDP-N-acetylglucosamine:alpha-6-D-mannoside beta1,6 N-acetylglucosaminyltransferase V (Mgat5) deficient mice |
| Q37957027 | Understanding glycomechanics using mathematical modeling: a review of current approaches to simulate cellular glycosylation reaction networks. |
| Q67902113 | Use of N-acetylglucosaminyltransferases I and II in the preparative synthesis of oligosaccharides |
| Q38348707 | Use of Synthetic Oligosaccharide Substrate Analogs to Map the Active Sites of N-Acetylglucosaminyltransferases I and II |
| Q38055447 | With or Without Sugar? (A)glycosylation of Therapeutic Antibodies |
| Q27627480 | X-ray crystal structure of rabbit N-acetylglucosaminyltransferase I: catalytic mechanism and a new protein superfamily |
Search more.